Vectored immunoprophylaxis (VIP) injection triggers creation of antibodies that prevent malaria in 70 percent of mice
A study led by Johns Hopkins Bloomberg School of Public Health researchers found that injecting a vaccine-like compound into mice was effective in protecting them from malaria. The findings suggest a potential new path toward the elusive goal of malaria immunization.
Mice injected with a virus genetically altered to help the rodents create an antibody designed to fight the malaria parasite produced high levels of the anti-malaria antibody. The approach, known as Vector immunoprophylaxis, or VIP, has shown promise in HIV studies. It had never before been tested with malaria, for which no licensed vaccine exists.
A report on the research appears online Aug. 11 in the Proceedings of the National Academy of Sciences (PNAS).
Malaria is one of the world’s deadliest infectious diseases, killing as many as 1 million people per year, the majority of them children in Africa. Malaria patients get the disease from infected mosquitoes. Of the four types of malaria that affect humans, the parasite Plasmodium falciparum is the most lethal, responsible for the majority of malaria cases. Antimalarial treatments and mosquito habitat modification have contributed to a decline in malaria mortality. But the number of cases remains high, and stemming them is a top global health priority.
In their study, researchers used a virus containing genes that were encoded to produce an antibody targeted to inhibit P. falciparum infection. Up to 70 percent of the mice injected with the VIP were protected from malaria-infected mosquito bites. In a subset of mice that produced higher levels of serum antibodies, the protection was 100 percent. The mice were tested a year after receiving a single injection of the virus and were shown to still produce high levels of the protective antibody.
The Latest on: Malaria vaccine
via Google News
The Latest on: Malaria vaccine
- Africa: We Studied the Sounds of Mosquitoes' Mating Rituals - Our Findings Could Help Fight Malariaon January 16, 2022 at 3:09 am
Analysis - In 2020, the World Health Organization (WHO) estimated that almost half the world's population was at risk of malaria, while some 627,000 people died from the disease.
- Doctors Raise Alarm as Malaria Outbreak Hits Kericho, Over 40 Locals Admittedon January 15, 2022 at 7:43 am
About 33 patients were admitted at Litein Mission Hospital while an unknown number of people were admitted at the Kapkatet Hospital in Bureti constituency.
- Vir to extend COVID-19 treatment approach to HIV, malaria with $50M from Gates Foundationon January 14, 2022 at 10:51 am
The Bill & Melinda Gates Foundation has committed $40 million in equity investment and $10 million in grant funding to Vir Biotechnology for the development of therapies against HIV and ...
- Opinion: We studied the sounds of mosquitoes’ mating rituals – our findings could help fight malariaon January 14, 2022 at 5:24 am
Managing the mosquito population is increasingly important as infections related to the insect are expected to rise due to climate change, argue Professor Joerg Albert, Dr Alex Alampounti (both UCL ...
- Vir Biotech launches new research programme for HIV and malaria preventionon January 14, 2022 at 4:33 am
Using antibody research, Vir will combine its existing immunology and virology expertise with the Gates Foundation ...
- COVID-19's silver lining: speeding vaccine tech for other diseaseson January 14, 2022 at 12:00 am
Scientists have been working with mRNA technology for more than two decades, and many believe that it can produce vaccines against cancer, malaria, heart disease, HIV and other diseases.
- Vir Biotechnology, Gates Foundation expand partnership for treating HIV, malariaon January 13, 2022 at 8:29 am
Vir Biotechnology expanded its partnership with the Bill & Melinda Gates Foundation to advance technologies for developing broadly neutralizing antibodies designed to ...
- Vir Biotechnology Launches New Antibody Research Initiative Aimed at a Functional Cure for HIV and Prevention of Malariaon January 13, 2022 at 6:05 am
New commitment from the Bill & Melinda Gates Foundation supports the development of Vir’s novel “vaccinal antibody” technology as another important step in the fight to address global infectious ...
- Fighting Vaccine Hesitancyon January 7, 2022 at 3:30 am
In 2019, tens of thousands of Americans took an unproven COVID treatment—hydroxychloroquine—because a persuasive politician convinced them of its merits. So often, the message is more important than ...
- Malaria Vaccines Market Size, Share, Trends and Forecast 2021-2030on January 7, 2022 at 12:43 am
In a recent published report, Kenneth Research has updated the market report for Malaria Vaccines Market for 2021 till 2030. Report further now di ...
via Bing News